COVID-19

Optical Coherence Tomography (OCT) for Ophthalmology Global Market Report 2022: Featuring Key Players Canon, Novacam Technologies, Thorlabs & Others

Staff July 14, 2022

DUBLIN, July 14, 2022 /PRNewswire/ -- The "Optical Coherence Tomography (OCT) for Ophthalmology - Global Market Trajectory & Analytics" report has...

WELL Forms Canadian Clinics Business Unit, Expands Credit Agreement, and Ramps up Clinic Growth

Staff July 14, 2022

WELL forms a new business unit to consolidate its Canadian outpatient clinic businesses into a highly integrated national 'bricks and...

Tianlong launched a campaign to care for SMA children

Staff July 14, 2022

XI'AN China, July 14, 2022 /PRNewswire/ -- Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care...

NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors

Staff July 14, 2022

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...

Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022

Staff July 14, 2022

Demonstrates OBDS Device Performance and Bioavailability in Animal ModelsSAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...

Chiesi tracks actions taken for a healthier, more sustainable future

Staff July 14, 2022

Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces...

Alignment Healthcare to Enter Texas in 2023, Introducing Its Award-Winning Medicare Advantage Plans to Medicare-Eligible Adults in El Paso, Hudspeth Counties

Staff July 14, 2022

ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details...

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients

Staff July 14, 2022

Groundbreaking Medical Device Company Unveils AI-Powered Software that Improves Diagnostic Imaging Experience for Young PatientsAUSTIN, Texas, July 14, 2022 (GLOBE...

Revelation Biosciences Inc. Completes Database Lock for its Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

Staff July 14, 2022

-Topline Data expected in the last week of July-SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:...

Summit Therapeutics Provides Update on Ridinilazole

Staff July 14, 2022

Menlo Park, CA, July 14, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today...

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets

Staff July 14, 2022

Strengthens balance sheet with non-dilutive capital at an attractive cost Competitive process results in the sale of 30% of the...

Vir Biotechnology Announces Transition of Chief Scientific Officer

Staff July 14, 2022

SAN FRANCISCO, July 14, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Herbert “Skip” Virgin, M.D.,...

AIM ImmunoTech to Present at the Virtual Investor Innovations in Oncology Spotlight Series

Staff July 14, 2022

Live video webcast with moderated roundtable between members of the AIM ImmunoTech Management Team and Key Opinion Leader Professor C.H.J....

Vaxart to Present Preclinical and Clinical Data From Its COVID-19 Oral Tablet Vaccine Program at ICMI 2022

Staff July 14, 2022

SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker,...

GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil

Staff July 14, 2022

SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the...

PDS Biotechnology Announces Presentation of Universal Flu Vaccine Preclinical Data at the 41st American Society of Virology Meeting

Staff July 14, 2022

PDS0202 neutralized multiple strains of influenza and provided protection against infection in preclinical studiesFLORHAM PARK, N.J., July 14, 2022 (GLOBE...

COVID-19

Optical Coherence Tomography (OCT) for Ophthalmology Global Market Report 2022: Featuring Key Players Canon, Novacam Technologies, Thorlabs & Others

WELL Forms Canadian Clinics Business Unit, Expands Credit Agreement, and Ramps up Clinic Growth

Tianlong launched a campaign to care for SMA children

NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors

Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022

Chiesi tracks actions taken for a healthier, more sustainable future

Alignment Healthcare to Enter Texas in 2023, Introducing Its Award-Winning Medicare Advantage Plans to Medicare-Eligible Adults in El Paso, Hudspeth Counties

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients

Revelation Biosciences Inc. Completes Database Lock for its Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis

Summit Therapeutics Provides Update on Ridinilazole

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets

Vir Biotechnology Announces Transition of Chief Scientific Officer

AIM ImmunoTech to Present at the Virtual Investor Innovations in Oncology Spotlight Series

Vaxart to Present Preclinical and Clinical Data From Its COVID-19 Oral Tablet Vaccine Program at ICMI 2022

GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil

PDS Biotechnology Announces Presentation of Universal Flu Vaccine Preclinical Data at the 41st American Society of Virology Meeting

Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company

Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing

Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors

TOWER ONE WIRELESS ANNOUNCES TWENTY-TWO TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 2,600,000

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

Reel Vision Studios Seeks Active Investor to Support Expansion in Video Production and Livestream Services

NCQA Focuses on Improving Asthma Outcomes in New Whitepaper

You may have missed